United States
Germany
Japan
United Kingdom
China
CD18 (ITGB2) rat monoclonal antibody, clone YFC118.3, Purified
| Applications | FC, IHC, IP |
| Reactivities | Canine, Human |
Antibodies
Cd8b1 mouse monoclonal antibody, clone CA15.4G2, Supernatant
| Applications | FC, IHC, IP |
| Reactivities | Canine |
CD79B rat monoclonal antibody, clone AT107-2, Purified
| Applications | ELISA, IP, WB |
| Reactivities | Canine, Human, Mouse, Porcine, Rat |
CD47 mouse monoclonal antibody, clone BRIC-126, Purified
| Applications | FC, IHC, IP |
| Reactivities | Bovine, Canine, Human, Porcine, Sheep |
CD11c mouse monoclonal antibody, clone CA11.6A1, Supernatant
| Applications | FC, IHC, IP |
| Reactivities | Canine |
Cytochrome C (CYCS) sheep polyclonal antibody, Purified
| Applications | IHC, IP, WB |
| Reactivities | Canine, Human, Rabbit, Rat |
BCL2 sheep polyclonal antibody, Purified
| Applications | IF, IP, WB |
| Reactivities | Canine, Human, Rat |
Canine IgG (Fc specific) goat polyclonal antibody, Azide Free
| Applications | Can be used as unlabelled primary or secondary reagent for indirect detection of IgG at the cellular and subcellular level by staining of appropriately treated cell and tissue substrates; to prepare conjugates of the user’s own choice; to prepare an insoluble immunoaffinity adsorbent or a solid phase antibody reagent by coupling to an artificial carrier and as catching antibody in non-isotopic methodology and solid phase immunochemistry. When applied in any cytochemical or histochemical staining procedure or solid phase coupling technique, the optimum concentration of the IgG preparation should be established by titration before being used. Typical working dilutions: In histochemistry are usually between 1/50 and 1/250. In ELISA and comparable non-precipitating antibody-binding assays between 1/1000 and 1/5000. |
| Reactivities | Canine |
| Conjugation | Unconjugated |
Canine IgA (Fc specific) goat polyclonal antibody, Azide Free
| Applications | Can be used as unlabelled primary or secondary reagent for indirect detection techniques, to prepare conjugates with markers of the user’s own choice, to prepare an insoluble immunoaffinity adsorbent or a solid phase antibody reagent by coupling to an artificial carrier and as catching or detection antibody in non-isotopic methodology and solid phase immunochemistry. When applied in any cytochemical or histochemical procedure or solids phase coupling technique, the optimum concentration of the IgG preparation should always be established by titration. Typical working dilutions: In histochemistry are usually between 1/50 and 1/250. In ELISA and comparable non-precipitating antibody-binding assays between 1/500 and 1/2000. |
| Reactivities | Canine |
| Conjugation | Unconjugated |
Canine IgM (Fc specific) goat polyclonal antibody, Azide Free
| Applications | As unlabelled primary or secondary reagent for indirect detection techniques, to prepare conjugates with markers of the user’s own choice, to prepare an insoluble immunoaffinity adsorbent or a solid phase antibody reagent by coupling to an artificial carrier and as catching or detection antibody in non-isotopic methodology and solid phase immunochemistry. When applied in any cytochemical or histochemical procedure or solids phase coupling technique, the optimum concentration of the IgG preparation should always be established by titration. Typical working dilutions: In histochemistry are usually between 1/50 and 1/250. In ELISA and comparable non-precipitating antibody-binding assays between 1/500 and 1/3000. |
| Reactivities | Canine |
| Conjugation | Unconjugated |
Fibrinogen goat polyclonal antibody, Azide Free
| Applications | ID, IP |
| Reactivities | Canine |
活动过滤器
优化搜索结果
Target Symbol
- MLANA (6)
- AFP (4)
- EGFR (4)
- IVL (4)
- MAGEA1 (4)
- TNF (4)
- VIM (4)
- ITGA6 (3)
- TLR4 (3)
- ACTA2 (2)
- CASPASE 9 (2)
- CD40 (2)
- CD47 (2)
- CD79B (2)
- FCGR2A (2)
- HIF-1 ALPHA (2)
- HSPD1 (2)
- ICAM1 (2)
- ITGB2 (2)
- MAPK14 (2)
- MAPKAPK5 (2)
- MSH6 (2)
- MYOG (2)
- P53 (2)
- TIMP3 (2)
- TLR3 (2)
- AFDN (1)
- AIF (1)
- ARHGEF2 (1)
- BCL2 (1)
- CALR (1)
- CAPICUA (1)
- CASPASE 3 (1)
- CASPASE-6 (1)
- CD3E (1)
- CD4 (1)
- CD44 (1)
- CD79A (1)
- CD80 (1)
- CD8A (1)
- CD8B (1)
- CR2 (1)
- CTNNA1 (1)
- CTNNB1 (1)
- CYCS (1)
- DBN1 (1)
- DREBRIN (1)
- ELASTIN (1)
- GP9 (1)
- HSP40 (1)
- IKB ALPHA (1)
- IL3RA (1)
- IL7R (1)
- INVOLUCRIN (1)
- ITGAM (1)
- ITGB1 (1)
- LBP (1)
- LIMPII (1)
- MAPK1 (1)
- MAPK3 (1)
- MAPK6 (1)
- MAPKAPK2 (1)
- NOS1 (1)
- PKC ALPHA (1)
- PKP2 (1)
- PKP3 (1)
- SODIUM POTASSIUM ATPASE (1)
- SPP1 (1)
- STAT3 (1)
- TBK1 (1)
- THBS1 (1)
- TLR2 (1)
- TLR5 (1)
- TLR9 (1)
- TNNI3 (1)
- TRP 7 (1)
Antibody Hosts
Clonalities
Assay Types
Families
Pathways
- Toll-like receptor signaling pathway (10)
- Pathways in cancer (9)
- Apoptosis (8)
- Amyotrophic lateral sclerosis (ALS) (5)
- Colorectal cancer (5)
- Huntington's disease (5)
- Non-small cell lung cancer (5)
- Pathogenic Escherichia coli infection (5)
- Prostate cancer (5)
- Small cell lung cancer (5)
- p53 signaling pathway (5)
- Endometrial cancer (4)
- MAPK signaling pathway (4)
- Pancreatic cancer (4)
- Alzheimer's disease (3)
- Chronic myeloid leukemia (3)
- Glioma (3)
- Neurotrophin signaling pathway (3)
- Parkinson's disease (3)
- VEGF signaling pathway (3)
- Viral myocarditis (3)
- Wnt signaling pathway (3)
- Basal cell carcinoma (2)
- Bladder cancer (2)
- Cell cycle (2)
- Cytosolic DNA-sensing pathway (2)
- Epithelial cell signaling in Helicobacter pylori infection (2)
- Melanoma (2)
- Natural killer cell mediated cytotoxicity (2)
- RIG-I-like receptor signaling pathway (2)
- Renal cell carcinoma (2)
- Thyroid cancer (2)
- mTOR signaling pathway (2)
- Adipocytokine signaling pathway (1)
- B cell receptor signaling pathway (1)
- Calcium signaling pathway (1)
- Cardiac muscle contraction (1)
- Chemokine signaling pathway (1)
- ErbB signaling pathway (1)
- Fc epsilon RI signaling pathway (1)
- Fc gamma R-mediated phagocytosis (1)
- Focal adhesion (1)
- Gap junction (1)
- GnRH signaling pathway (1)
- Leukocyte transendothelial migration (1)
- Long-term depression (1)
- Long-term potentiation (1)
- Lysosome (1)
- Melanogenesis (1)
- NOD-like receptor signaling pathway (1)
- Phosphatidylinositol signaling system (1)
- T cell receptor signaling pathway (1)
- Tight junction (1)
- Vascular smooth muscle contraction (1)
- Vibrio cholerae infection (1)
